Clinical study results often have a direct impact on the perceived value and potential success of a company's product. Positive results can lead to increased investor confidence, higher demand for the product, and potentially an increase in the company's stock price. As the study directly involves PetVivo's product, the relevance is high. The importance is significant as it pertains to a core product that could drive future revenues. The confidence level is set to 85, acknowledging the general positive impact of successful clinical trials on a company's valuation, but also considering market variables that could affect the stock price.